Symbols / AXSM Stock $216.47 -0.42% Axsome Therapeutics, Inc.

Healthcare • Biotechnology • United States • NGM
AXSM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NGM · United States
Market Cap 11.53B
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $217.38
Price $216.47
Change -0.42%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest AXSM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
638.50
+65.55%
385.69
+42.53%
270.60
+440.80%
50.04
Operating Revenue
638.50
+65.55%
385.69
+42.53%
270.60
+440.80%
50.04
Cost Of Revenue
47.48
+42.56%
33.30
+27.77%
26.07
+401.44%
5.20
Reconciled Cost Of Revenue
44.79
+41.13%
31.74
+23.94%
25.61
+418.87%
4.93
Gross Profit
591.02
+67.72%
352.39
+44.11%
244.53
+445.36%
44.84
Operating Expense
760.25
+25.70%
604.83
+41.50%
427.44
+93.12%
221.34
Research And Development
183.28
-2.03%
187.08
+91.00%
97.94
+69.02%
57.95
Selling General And Administration
570.60
+38.71%
411.36
+27.31%
323.12
+102.90%
159.25
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Total Expenses
807.73
+26.58%
638.13
+40.71%
453.51
+100.19%
226.54
Operating Income
-169.24
+32.96%
-252.44
-38.01%
-182.91
-3.63%
-176.50
Total Operating Income As Reported
-166.76
+40.56%
-280.56
-21.02%
-231.82
-28.94%
-179.80
EBITDA
-168.08
+38.34%
-272.60
-21.16%
-224.99
-28.28%
-175.40
Normalized EBITDA
-160.17
+34.49%
-244.48
-38.85%
-176.07
-2.31%
-172.10
Reconciled Depreciation
9.06
+13.90%
7.96
+16.45%
6.83
+55.25%
4.40
EBIT
-177.15
+36.86%
-280.56
-21.02%
-231.82
-28.94%
-179.80
Total Unusual Items
-7.91
+71.87%
-28.12
+42.51%
-48.92
-1383.26%
-3.30
Total Unusual Items Excluding Goodwill
-7.91
+71.87%
-28.12
+42.51%
-48.92
-1383.26%
-3.30
Special Income Charges
-7.91
+71.87%
-28.12
+42.51%
-48.92
-1383.26%
-3.30
Other Special Charges
10.38
—
—
—
Restructuring And Mergern Acquisition
-2.47
-108.79%
28.12
-42.51%
48.92
+1383.26%
3.30
Net Income
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Pretax Income
-183.70
+36.02%
-287.13
-20.50%
-238.28
-27.33%
-187.13
Net Non Operating Interest Income Expense
-6.56
+0.18%
-6.57
-1.80%
-6.45
+12.02%
-7.33
Interest Expense Non Operating
6.56
-0.18%
6.57
+1.80%
6.45
-12.02%
7.33
Net Interest Income
-6.56
+0.18%
-6.57
-1.80%
-6.45
+12.02%
-7.33
Interest Expense
6.56
-0.18%
6.57
+1.80%
6.45
-12.02%
7.33
Other Income Expense
-7.91
+71.87%
-28.12
+42.51%
-48.92
-1383.26%
-3.30
Tax Provision
-0.53
-723.53%
0.09
-91.15%
0.96
0.00
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
0.00
Tax Effect Of Unusual Items
-0.02
0.00
+100.00%
-10.27
0.00
Net Income Including Noncontrolling Interests
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Net Income From Continuing Operation Net Minority Interest
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Net Income From Continuing And Discontinued Operation
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Net Income Continuous Operations
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Normalized Income
-175.29
+32.35%
-259.09
-29.16%
-200.59
-9.12%
-183.84
Net Income Common Stockholders
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Diluted EPS
-3.68
+38.56%
-5.99
-13.66%
-5.27
-14.57%
-4.60
Basic EPS
-3.68
+38.56%
-5.99
-13.66%
-5.27
-14.57%
-4.60
Basic Average Shares
49.75
+3.83%
47.91
+5.48%
45.43
+11.73%
40.66
Diluted Average Shares
49.75
+3.83%
47.91
+5.48%
45.43
+11.73%
40.66
Diluted NI Availto Com Stockholders
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Amortization
6.38
-0.27%
6.39
+0.27%
6.38
+54.02%
4.14
Amortization Of Intangibles Income Statement
6.38
-0.27%
6.39
+0.27%
6.38
+54.02%
4.14
Depreciation Amortization Depletion Income Statement
6.38
-0.27%
6.39
+0.27%
6.38
+54.02%
4.14
Depreciation And Amortization In Income Statement
6.38
-0.27%
6.39
+0.27%
6.38
+54.02%
4.14
Other Taxes
—
—
—
0.00
Line Item Trend 2023-12-31
Total Assets
588.24
Current Assets
504.26
Cash Cash Equivalents And Short Term Investments
386.19
Cash And Cash Equivalents
386.19
Cash Financial
—
Receivables
94.82
Accounts Receivable
94.82
Gross Accounts Receivable
107.32
Allowance For Doubtful Accounts Receivable
-12.50
Inventory
15.13
Prepaid Assets
—
Other Current Assets
8.12
Total Non Current Assets
83.97
Net PPE
7.62
Gross PPE
7.62
Properties
0.00
Buildings And Improvements
6.77
Other Properties
0.85
Goodwill And Other Intangible Assets
65.33
Goodwill
12.04
Other Intangible Assets
53.29
Other Non Current Assets
11.03
Total Liabilities Net Minority Interest
397.26
Current Liabilities
138.85
Payables And Accrued Expenses
110.72
Payables
40.68
Accounts Payable
40.68
Current Accrued Expenses
70.04
Pensionand Other Post Retirement Benefit Plans Current
20.46
Total Tax Payable
0.00
Current Debt And Capital Lease Obligation
1.27
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
1.27
Other Current Liabilities
6.41
Total Non Current Liabilities Net Minority Interest
258.40
Long Term Debt And Capital Lease Obligation
185.10
Long Term Debt
178.07
Long Term Capital Lease Obligation
7.04
Other Non Current Liabilities
73.30
Stockholders Equity
190.98
Common Stock Equity
190.98
Capital Stock
0.01
Common Stock
0.01
Preferred Stock
0.00
Share Issued
47.35
Ordinary Shares Number
47.35
Treasury Shares Number
0.00
Additional Paid In Capital
1,026.54
Retained Earnings
-835.57
Total Equity Gross Minority Interest
190.98
Total Capitalization
369.05
Working Capital
365.41
Invested Capital
369.05
Total Debt
186.37
Capital Lease Obligations
8.30
Net Tangible Assets
125.65
Tangible Book Value
125.65
Interest Payable
1.66
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-93.41
+27.26%
-128.41
+11.49%
-145.08
-24.52%
-116.51
Cash Flow From Continuing Operating Activities
-93.41
+27.26%
-128.41
+11.49%
-145.08
-24.52%
-116.51
Net Income From Continuing Operations
-183.17
+36.22%
-287.22
-20.05%
-239.24
-27.84%
-187.13
Depreciation Amortization Depletion
9.06
+13.90%
7.96
+16.45%
6.83
+55.25%
4.40
Depreciation
2.69
+71.71%
1.57
+241.18%
0.46
+74.52%
0.26
Amortization Cash Flow
6.38
-0.27%
6.39
+0.27%
6.38
+54.02%
4.14
Depreciation And Amortization
9.06
+13.90%
7.96
+16.45%
6.83
+55.25%
4.40
Amortization Of Intangibles
6.38
-0.27%
6.39
+0.27%
6.38
+54.02%
4.14
Other Non Cash Items
-0.91
-102.86%
31.73
-40.24%
53.10
+1000.44%
4.83
Stock Based Compensation
93.75
+10.01%
85.22
+36.09%
62.62
+65.99%
37.73
Operating Gains Losses
10.38
—
—
—
Change In Working Capital
-22.52
-166.44%
33.90
+219.40%
-28.39
-219.95%
23.67
Change In Receivables
-82.46
-74.78%
-47.18
+17.40%
-57.12
-51.52%
-37.70
Changes In Account Receivables
-82.46
-74.78%
-47.18
+17.40%
-57.12
-51.52%
-37.70
Change In Inventory
-15.67
-542.48%
-2.44
+45.34%
-4.46
+15.41%
-5.28
Change In Prepaid Assets
-1.67
+56.69%
-3.86
+27.59%
-5.33
-95.06%
-2.73
Change In Payables And Accrued Expense
77.28
-11.56%
87.38
+126.82%
38.53
-44.47%
69.38
Change In Accrued Expense
83.74
+49.37%
56.06
+53.81%
36.45
-17.01%
43.92
Change In Payable
-6.46
-120.63%
31.32
+1410.03%
2.07
-91.85%
25.46
Change In Account Payable
-6.46
-120.63%
31.32
+1410.03%
2.07
-91.85%
25.46
Change In Other Current Assets
—
—
—
—
Investing Cash Flow
-0.48
-77.78%
-0.27
+53.61%
-0.58
+98.92%
-53.70
Cash Flow From Continuing Investing Activities
-0.48
-77.78%
-0.27
+53.61%
-0.58
+98.92%
-53.70
Net PPE Purchase And Sale
-0.48
-77.78%
-0.27
+53.61%
-0.58
+17.09%
-0.70
Purchase Of PPE
-0.48
-77.78%
-0.27
+53.61%
-0.58
+17.09%
-0.70
Capital Expenditure
-0.48
-77.78%
-0.27
+53.61%
-0.58
+17.09%
-0.70
Net Business Purchase And Sale
—
0.00
0.00
+100.00%
-53.00
Purchase Of Business
—
0.00
0.00
+100.00%
-53.00
Financing Cash Flow
101.47
+75.42%
57.84
-82.53%
331.01
+16.32%
284.58
Cash Flow From Continuing Financing Activities
101.47
+75.42%
57.84
-82.53%
331.01
+16.32%
284.58
Net Issuance Payments Of Debt
-4.11
-315.35%
-0.99
-101.16%
85.00
+88.89%
45.00
Issuance Of Debt
330.00
0.00
-100.00%
85.00
+88.89%
45.00
Repayment Of Debt
-334.11
-33648.69%
-0.99
0.00
0.00
Long Term Debt Issuance
330.00
0.00
-100.00%
85.00
+88.89%
45.00
Long Term Debt Payments
-334.11
-33648.69%
-0.99
0.00
0.00
Net Long Term Debt Issuance
-4.11
-315.35%
-0.99
-101.16%
85.00
+88.89%
45.00
Net Common Stock Issuance
67.90
+66.50%
40.78
-84.24%
258.75
+6.15%
243.76
Proceeds From Stock Option Exercised
59.56
+94.13%
30.68
+147.04%
12.42
+98.67%
6.25
Net Other Financing Charges
-21.89
-73.22%
-12.63
+49.78%
-25.16
-141.14%
-10.43
Changes In Cash
7.58
+110.70%
-70.84
-138.22%
185.35
+62.06%
114.37
Beginning Cash Position
315.35
-18.34%
386.19
+92.29%
200.84
+132.26%
86.47
End Cash Position
322.93
+2.40%
315.35
-18.34%
386.19
+92.29%
200.84
Free Cash Flow
-93.89
+27.04%
-128.68
+11.66%
-145.66
-24.27%
-117.21
Interest Paid Supplemental Data
14.63
-25.72%
19.69
+17.69%
16.73
+117.67%
7.69
Common Stock Issuance
67.90
+66.50%
40.78
-84.24%
258.75
+6.15%
243.76
Issuance Of Capital Stock
67.90
+66.50%
40.78
-84.24%
258.75
+6.15%
243.76
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category